Product Information
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) is a generic product labeled by Hospira Inc., priced at $0.7413 per ML under NDC 00409330803. Its NADAC has been published 573 times since Nov 28, 2013.
FDA first approved this application on Aug 30, 1994. Its Orange Book therapeutic-equivalence code is AN.
The Low Outlier badge above means this manufacturer's average price in the ACETYLCYSTEINE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/mL
Manufacturer
Hospira Inc.NDC
00409330803
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL; RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
ACETYLCYSTEINEApproval Type
Generic (ANDA)
FDA Application
ANDA074037FDA Approved
8/30/1994
TE Code
AN
On Market Since
6/1/2005
Pharmacological Classes
Price Statistics
The NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has been published 573 times since Nov 28, 2013, and over the history we have for it it has risen 135.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7413 per ML |
|---|---|
| All-time high | $0.7751 (Aug 14, 2024) |
| All-time low | $0.2303 (Feb 19, 2014) |
| 52-week high | $0.7447 |
| 52-week low | $0.6011 |
| Median price | $0.3333 |
| Average price | $0.4033 |
| Largest weekly change | +108.4% (Apr 17, 2024) |
| Weeks tracked | 573 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
The current National Average Drug Acquisition Cost (NADAC) for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION), manufactured by Hospira Inc., is $0.7413 per ML (NDC 00409330803), effective Aug 19, 2026.
How has the price of ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) changed over time?
Over the history we have for it, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has risen 135.2%. It has been tracked across 573 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
Since Nov 28, 2013, the NADAC for ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) has ranged from a low of $0.2303 (Feb 19, 2014) to a high of $0.7751 (Aug 14, 2024), with a median of $0.3333 per ML.
Are there cheaper alternatives to ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) in a comparable dosage form, but none are currently priced below it.
Who manufactures ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION)?
ACETYLCYSTEINE 20% VIAL (NOT FOR INJECTION) (NDC 00409330803) is labeled by Hospira Inc., and CMS classifies it as a generic product.